AHR and obesity due to melanocortin 4 receptor deficiency: In obese individuals, the level of indole is reduced, leading to the disruption of its role in enhancing the intestinal barrier and improving metabolic homeostasis after binding with AhR, while the accumulation of kynurenine promotes inflammation, energy imbalance, and fat deposition, ultimately resulting in obesity [27,28].